Previous Article | Next Article ![]()
Antimicrobial Agents and Chemotherapy, August 1999, p. 1856-1861, Vol. 43, No. 8
Molecular Microbiology Section, Laboratory of
Clinical Investigation, National Institute of Allergy and
Infectious Diseases, Bethesda, Maryland 208921;
University Hospital of Verona, Verona,
Italy2; and Hadassah Medical Center,
Jerusalem, Israel3
Received 28 December 1998/Returned for modification 1 February
1999/Accepted 19 May 1999
Cryptococcus neoformans isolates that exhibited unusual
patterns of resistance to fluconazole and voriconazole were isolated from seven isolates from two different geographical regions: one isolate from an Israeli non-AIDS patient and six serial isolates from
an Italian AIDS patient who had suffered six recurrent episodes of
cryptococcal meningitis. Each isolate produced cultures with heterogeneous compositions in which most of the cells were susceptible, but cells highly resistant to fluconazole (MICs,
0066-4804/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Heteroresistance to Fluconazole and Voriconazole in
Cryptococcus neoformans
64 µg/ml) were recovered at a variable frequency (7 × 10
3 to
4.6 × 10
2). Evidence showed that this type of
resistance is innate and is unrelated to drug exposure since the
Israeli patient had never been treated with azoles or any other
antimycotic agents. Analysis of clonal subpopulations of these two
strains showed that they exhibited heterogeneous patterns of
resistance. The number of subpopulations which grew on fluconazole or
voriconazole agar declined progressively with increasing azole
concentration without a sharp cutoff point. For the Italian serial
isolates, the number of clonal populations resistant to fluconazole (64 µg/ml) and voriconazole (1 µg/ml) increased steadily, yielding the
highest number for the isolate from the last episode. Attempts to
purify a sensitive subpopulation failed, but clones highly resistant to
fluconazole (100 µg/ml) and moderately resistant to voriconazole (1 µg/ml) always produced a homogeneous population of resistant cells.
Upon maintenance on drug-free medium, however, the majority of the
homogeneously resistant cells of these subclones lost their resistance
and returned to the stable initial heteroresistant phenotype. The
pattern of heteroresistance was not affected by the pH or osmolarity of
the medium but was influenced by temperature. The resistance appeared
to be suppressed at 35°C and was completely abolished at 40°C.
Although heterogeneity in azole resistance among subpopulations of
single isolates has been reported for Candida species, the
transient changes in expression of resistance under different growth
conditions reported here have not been observed in fungal pathogens.
*
Corresponding author. Mailing address: MMS, LCI, NIAID,
Bldg. 10, 11C304, National Institutes of Health, Bethesda, MD 20892. Phone: (301) 496-1602. Fax: (301) 402-1003. E-mail:
June_Kwon-chung{at}nih.gov.
This article has been cited by other articles:
| Clin. Vaccine Immunol. | Clin. Microbiol. Rev. |
|---|---|
| J. Clin. Microbiol. | ALL ASM JOURNALS |